View in EDS HTML Full Text PDF Full Text

Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone.

Saved in:
Bibliographic Details
Title: Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone.
Authors: Bennett, Millicent G. A.1 (AUTHOR), Meakin, Ashley S.1,2 (AUTHOR), Botting-Lawford, Kimberley J.2,3 (AUTHOR), Niu, Youguo1,2 (AUTHOR), Ford, Sage G.2 (AUTHOR), Murphy, Michael P.3 (AUTHOR), Wiese, Michael D.1 (AUTHOR), Giussani, Dino A.2 (AUTHOR), Morrison, Janna L.1 (AUTHOR) janna.morrison@unisa.edu.au
Source: Pharmaceutics. Mar2025, Vol. 17 Issue 3, p285. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics17030285